What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?

Journal of Clinical Laboratory Analysis
Mesude FalayGülsüm Özet

Abstract

This study is a retrospective evaluation of patients who were subject to mixing study in our laboratory due to prolonged APTT. The preliminary diagnoses, clinical manifestations, and results of additional ordered tests were reviewed. The study aims to investigate whether repeating APTT test with a different assay prior to performing mixed study in patients with prolonged APTT would be a better alternative algorithmic approach in order to save both time and costs. We retrospectively evaluated 166 patients (65 females and 101 males) who were subject to mixing study due to isolated prolonged APTT. Additional ordered tests to identify the etiology and clinical findings were reviewed. All patients who had prolonged APTT as a result of testing with Hemosil Synthasil APTT reagent in ACL TOP analyzer were repeated with Stago Cephascreen APTT reagent in STA-R coagulation analyzer. APTT test was requested preoperatively in 72.2% of cases. Only 6.6% of the cases had history of bleeding. Correction with mixing study was achieved in 122 (73.5%) cases, among which 75 (45%) cases were found to have APTT test results within reference range when tested with Cephascreen reagent. In 44 (26.5%) cases, mixing study did not result in correction. Onl...Continue Reading

References

Dec 17, 2008·Seminars in Thrombosis and Hemostasis·Giuseppe Lippi, Emmanuel J Favaloro
May 8, 2010·International Journal of Laboratory Hematology·M MilosR Zadro
Sep 16, 2010·International Journal of Laboratory Hematology·A BowyerM Makris
Feb 1, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Emmanuel J Favaloro, Giuseppe Lippi
May 16, 2012·American Journal of Clinical Pathology·George A FritsmaEllinor I Peerschke
Jul 20, 2012·American Journal of Hematology·Oxana TcherniantchoukMarisa B Marques
Oct 25, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Giuseppe Lippi, Emmanuel J Favaloro
Nov 2, 2012·International Journal of Laboratory Hematology·I JenningsI D Walker
Mar 5, 2013·Seminars in Thrombosis and Hemostasis·Geoffrey Kershaw, Daniel Orellana
Aug 21, 2013·Autoimmunity Reviews·Massimo CugnoPier Luigi Meroni
Feb 11, 2014·Seminars in Thrombosis and Hemostasis·Kandice Kottke-Marchant
Mar 19, 2014·International Journal of Laboratory Hematology·S E ThorellJ Thachil
Sep 23, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Giuseppe Lippi, Emmanuel J Favaloro
Dec 3, 2014·Anaesthesia·A Fowler, D J Perry
May 30, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Éva AjznerUNKNOWN joint Working Group on Postanalytical Phase (WG-POST) of the European Federation of Clinical Chemistry and Laboratory Medici
Jan 16, 2016·International Journal of Laboratory Hematology·J Thachil
Apr 14, 2016·Seminars in Thrombosis and Hemostasis·Giuseppe LippiEmmanuel J Favaloro

❮ Previous
Next ❯

Citations

Jul 20, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·Emmanuel J FavaloroGiuseppe Lippi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.